Table 2. Examples of pathways identified from Ingenuity Pathway Analysis (IPA) in females and males.
Pathway | Molecules | |||||||
---|---|---|---|---|---|---|---|---|
Females | ||||||||
PS-T1 | PS-T2 | IS-T1 | IS-T2 | |||||
Biomarkers | Total Number of Biomarkers | Biomarkers | Total Number of Biomarkers | Biomarkers | Total Number of Biomarkers | Biomarkers | Total Number of Biomarkers | |
Atherosclerosis Signaling | CXCL8 | 1 | CXCL8, TGF-β1, TNF | 3 | CXCL8 | 1 | CSF1, CXCL8, IL-1β, TGF-β1, TNF | 5 |
Chemokine Signaling | 0 | 0 | 0 | 0 | ||||
Males | ||||||||
Atherosclerosis Signaling | CXCL12, CXCL8, IL-1 β | 3 | CSF1, CXCL12, CXCL8, IL-1β, PDGFΒ, TGF-β1 | 6 | CSF1, CXCL12, CXCL8, IL-1β | 4 | CSF1, CXCL12, CXCL8, IL-1β, PDGFΒ, TGF- β1 | 6 |
Chemokine Signaling | CCL5, CXCL12 | 2 | CXCL12 | 1 | CCL5, CXCL12 | 2 | CCL5, CXCL12 | 2 |